-transparent.png){kind=logo}
The capacity of angiogenin (Ang) to induce blood vessel growth is critically dependent on its ribonucleolytic activity. Crystallography and mutagenesis of human Ang have previously shown that its pyrimidine binding site is obstructed by Gln-117, implying that a conformational change is a key part of the mechanism of Ang action. The 1.5-A-resolution crystal structure of bovine Ang, in which glutamic acid is substituted for Gln-117, now confirms that a blocked active site is characteristic of these proteins. Indeed, the inactive conformation of bovine Ang is stabilized by a more extensive set of interactions than is that of human Ang. The three-dimensional structure of the putative receptor binding site is also well conserved in the two proteins. The Arg-Gly-Asp segment of this site in bovine Ang, which is replaced by Arg-Glu-Asn in human Ang, does not have a conformation typical of an integrin recognition site.
K R Acharya, and
R Shapiro, and
J F Riordan, and
B L Vallee
September 1994,
The Journal of biological chemistry,
K R Acharya, and
R Shapiro, and
J F Riordan, and
B L Vallee
March 1998,
The EMBO journal,
K R Acharya, and
R Shapiro, and
J F Riordan, and
B L Vallee
June 2010,
International journal of biological macromolecules,
K R Acharya, and
R Shapiro, and
J F Riordan, and
B L Vallee
March 2000,
Journal of molecular biology,
K R Acharya, and
R Shapiro, and
J F Riordan, and
B L Vallee
September 2010,
Proteins,
K R Acharya, and
R Shapiro, and
J F Riordan, and
B L Vallee
December 1998,
The EMBO journal,
K R Acharya, and
R Shapiro, and
J F Riordan, and
B L Vallee
May 1994,
Acta crystallographica. Section D, Biological crystallography,
K R Acharya, and
R Shapiro, and
J F Riordan, and
B L Vallee
November 2006,
Proteins,
K R Acharya, and
R Shapiro, and
J F Riordan, and
B L Vallee
February 1990,
Biochemistry,
K R Acharya, and
R Shapiro, and
J F Riordan, and
B L Vallee
December 1987,
Biochemistry,
